Check this table to make sure you can use your COPD inhalers together Medically reviewed by Sanja Jelic, MD Most people with ...

Although these products might confer significant advantages over the currently available treatments, there is still a huge unmet need for drugs that prevent the progression of COPD. Companies are ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This in-depth analysis shows that the Global Asthma and COPD Drugs Market, valued at ...

It plans to estimate the "comparative therapeutic impact" of the two drugs compared to their respective ... in patients with moderate to severe COPD. So far, attempts by the industry to strike ...

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those taking DPP-4 drugs.

Medically reviewed by Sanja Jelic, MD Chronic obstructive pulmonary disease (COPD), an irreversible form of lung disease, is ...

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

A new study suggests COPD patients experience improved lung function ... and failed to show superiority to the older drugs in head-to-head trials. Novartis, by contrast, can claim superiority ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive ...